Insulin differentially altered transcapillary movement in isolated rat hearts, increasing subendothelial IGFBP-1 content up to 132% (p<0.05) while decreasing ECBP content to 62% (p<0.005).
Does insulin alter the transcapillary movement of IGF-binding proteins in isolated rat hearts?
Insulin differentially alters the transcapillary movement of specific IGF-binding proteins in the rat heart, suggesting a mechanism for nutrient-dependent transport of IGFs to peripheral tissues.
Insulin-like growth factor binding-proteins 1 and 2 (IGFBP-1, IGFBP-2) and endothelial cell IGF binding proteins (ECBP) were individually perfused through isolated beating rat hearts in the absence and presence of insulin. Insulin caused an increased movement of IGFBP-1 from the vascular space to tissues of the heart. Subendothelial content of IGFBP-1 was 110%, 126% (p less than .01) and 132% (p less than 0.05) of control hearts when perfused with 1, 10 and 100 ng/ml insulin, respectively. . In contrast, insulin treatment was associated with a decrease in ECBP content in cardiac tissue, being 83%, 62% (p less than 0.005) and 73% (p less than 0.05) of control when perfused with 1, 10 and 100 ng/ml insulin. The efflux of IGFBP-2 from the intravascular space was unaffected by insulin. The subendothelial tissue distribution of the transported binding proteins was not changed by insulin perfusion, with IGFBP-1 and IGFBP-2 localizing predominantly in cardiac muscle and ECBP having greater affinity for connective tissue elements. We conclude that in the perfused rat heart, insulin can differentially alter transcapillary movement of IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins. Such insulin-facilitated changes could potentially mediate nutrient-dependent transport of IGF-I and IGF-II to peripheral tissues.
Bar et al. (Sun,) reported a other. Insulin vs. Absence of insulin (control) was evaluated on Transcapillary movement of IGFBP-1, IGFBP-2, and ECBP. Insulin differentially altered transcapillary movement in isolated rat hearts, increasing subendothelial IGFBP-1 content up to 132% (p<0.05) while decreasing ECBP content to 62% (p<0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: